Effect of CETP polymorphism on atorvastatin lipid-regulating effect and clinical prognosis of patients with coronary heart disease - Wikidata - wikimedia - TriplyDB

Effect of CETP polymorphism on atorvastatin lipid-regulating effect and clinical prognosis of patients with coronary heart disease

Effect of CETP polymorphism on atorvastatin lipid-regulating effect and clinical prognosis of patients with coronary heart disease

http://www.wikidata.org/entity/Q34852756

about

Effects of LEP G2548A and LEPR Q223R Polymorphisms on Serum Lipids and Response to Simvastatin Treatment in Chinese Patients With Primary Hyperlipidemia.Paradoxical Elevation of High Density Lipoprotein Cholesterol in Association with Lacunar-Type Cerebral Infarction Cholesteryl ester transfer protein: ace of spades, queen of hearts, or the joker?A meta-analytic evaluation of cholesteryl ester transfer protein (CETP) C-629A polymorphism in association with coronary heart disease risk and lipid changes Seventeen years of statin pharmacogenetics: a systematic review.Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol (LDL-C): a randomised, double-blind, and cross-over placebo-controlled clinical trial

P2860

Q30277140-FD54DB53-2F90-4A11-A97B-E90872F0C562 Q35835430-2A261124-07B9-44D4-AE30-9A2BD14EBACE Q35847625-0683453C-C574-4BDD-B290-8E3B22778EB1 Q37709237-E85197B7-11A1-4CAD-BE8A-ABB725E31DDE Q38670109-8D1BACAE-818B-4E87-8C84-312154AC9965 Q58605286-C0841BF9-A537-4925-9DCD-588AC0B35A64

P2860

Effect of CETP polymorphism on atorvastatin lipid-regulating effect and clinical prognosis of patients with coronary heart disease

http://www.wikidata.org/entity/Q34852756

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effect of CETP polymorphism on ...... ts with coronary heart disease

@ast

Effect of CETP polymorphism on ...... ts with coronary heart disease

@en

Effect of CETP polymorphism on ...... ts with coronary heart disease

@nl

type

label

Effect of CETP polymorphism on ...... ts with coronary heart disease

@ast

Effect of CETP polymorphism on ...... ts with coronary heart disease

@en

Effect of CETP polymorphism on ...... ts with coronary heart disease

@nl

prefLabel

Effect of CETP polymorphism on ...... ts with coronary heart disease

@ast

Effect of CETP polymorphism on ...... ts with coronary heart disease

@en

Effect of CETP polymorphism on ...... ts with coronary heart disease

@nl

P1433

Q34852756-799663DF-550B-4B67-B2DD-71489AE5D0A1

P1476

Q34852756-03A27FE3-513A-4196-BA36-FAF8B80C0093

P2093

Q34852756-1CA80213-6B21-4C04-AE12-8DC6421CB7BE

Q34852756-3C7592DC-5714-48E8-B92F-F2DBF9B43445

Q34852756-441E53AF-69AA-405E-A904-98F588590BB2

Q34852756-74D2D657-1AF2-4D4B-9F87-E03A835D78A9

P2860

Q34852756-017BF372-8D0F-4504-B5B2-F03009F0DCC0

Q34852756-099EA2D8-2857-4268-93FC-ADA4DF494677

Q34852756-16351E7C-B366-497E-8AB8-2706D04CFFE6

Q34852756-176F1FF5-46BB-43E7-8EB3-834A1F6CEA34

Q34852756-2B745C02-3684-491A-8439-631A2A68D375

Q34852756-2EF0661B-5CEC-414A-BF4F-4504F36CC175

Q34852756-3123A088-5AAF-4837-B15A-B6F461131F8D

Q34852756-8D072E25-88AE-419B-B242-A85AE372E367

Q34852756-8E778092-27F2-470E-8C2E-78FCFFF6857F

Q34852756-92836795-D0CE-4E11-9C1E-406509410AF0

P304

Q34852756-6A21E0B4-28B8-42CC-A190-95C47299CC76

P31

Q34852756-3B2DD8BF-528F-4AC4-825F-52D02248D18E

P356

Q34852756-F7AAA6CF-C05D-40C6-98C5-42A9AA9275A7

P478

Q34852756-2070001E-41CE-4E24-8277-69489738173D

P577

Q34852756-ED2D1F42-16B8-4B44-81B6-778776157FFA

P698

Q34852756-362FECEA-71A7-4738-9D05-8B0F5BECBBCD

P932

Q34852756-9D2E245A-C77A-40F3-A799-313DB89F7F3B

P356

P1433

Medical Science Monitor

P1476

Effect of CETP polymorphism on ...... ts with coronary heart disease

@en

P2093

Guo-Long Gu

http://www.w3.org/2001/XMLSchema#string

Qing-You Yang

http://www.w3.org/2001/XMLSchema#string

Ruo-Long Zeng

http://www.w3.org/2001/XMLSchema#string

Xiao-Lin Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients

A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins

Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease.

Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of myocardial infarction in women of European ancestry

Clinical implications of pharmacogenomics of statin treatment.

New molecular insights into CETP structure and function: a review.

The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT study.

Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertensi

The use of dyslipidemic hamsters to evaluate drug-induced alterations in reverse cholesterol transport.

Emerging therapeutic strategies to enhance HDL function.

P304

2824-2829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.892711

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25547030

http://www.w3.org/2001/XMLSchema#string

P932

4285921

http://www.w3.org/2001/XMLSchema#string